FDA Elimination Of Neoral "Microemulsion" Designation Disputed By Novartis

FDA's elimination of "microemulsion" dosage forms is unlawful, Novartis contended in a Feb. 11 lawsuit challenging FDA's approval of SangStat's generic version of Neoral (cyclosporine).